Monique Ford / Stuff
Women were much more likely than men to have filed a claim, according to the ACC. (File photo)
Covid-19 vaccination claims linked to ACC injuries represent around 0.02% of the more than 9 million doses administered in New Zealand.
Figures released by the ACC show 1,708 vaccination injury claims since its deployment to the Kiwis in February 2021.
From February 18, 2021 to January 12, 2022, the ACC received 1,708 claims for “Covid vaccination-related injuries” with 627 claims accepted, 513 claims denied and 568 yet to be decided, according to the figures.
“A treatment injury is a personal injury caused as a result of seeking or receiving medical treatment or under the direction of a registered medical professional,” states the ACC.
“In order to meet the criteria for coverage, the person must have suffered a bodily injury and there must be a clear causal link between the treatment and the injury, and the injury must not be a necessary part or an ordinary consequence of the treatment. “
A breakdown by sex shows that 68% of requests (1,163) for treatment of vaccine-related injuries were from women.
ACC has received claims in all age groups from 12 to 85 and over. The 45-49 age group topped the list with 202 and the 12-14 age group had the fewest complaints with 23.
“The Comirnaty (the Pfizer-BioNTech vaccine) was until very recently the only Covid vaccine that has been used as part of New Zealand’s vaccine response, but more recently the Astra Zeneca Covid-19 vaccine has also been used,” the ACC said.
“The specific vaccine used is not always identified on the claim, so the identification of the vaccine used cannot be reliably determined.
“Given the vaccination policy, the vast majority of claims reported below relate to the Pfizer-BioNTech Comirnaty vaccine.”
Types of injuries
The ACC says treatment injuries were confirmed and recorded when a claim was decided with 627 accepted.
Allergic reaction tops the list with 150; followed by a sprain 71; bruise 70; anaphylactic reaction 66; adverse drug reaction 65; infections 40; cellulitis 31; heart lesion 23; nerve damage 12; bursitis 7; other 92.
According to the ACC, it is difficult to measure the impact of an injury on a person.
“The ACC and others use the overall cost of a treatment injury claim as an indicator of the severity of the injury, as more expensive claims are likely to indicate claims where there has been a more severe impact. on the injured person.
“While not always directly related, overall cost is a measure of severity and impact.”
Of the accepted claims, 59 had resulted in payments of more than $500 as of January 11, while 173 claims had yet to receive payment. The majority of accepted claims, 207, are in the under $100 category.
“To date, less than four claims have been filed with the ACC for fatal injury.”
People of European descent accounted for 70% (1198) of claims with a similar percentage accepted for coverage. Maori accounted for 9% (154) of applications made and 9% of applications granted.
Pacific people had the lowest complaints filed at only 69 (26 accepted), Asians at 149 (56 accepted) and the other/unknown category had 138 complaints (41 accepted).
The ACC was unable to specify the dose requested by people in almost 60% of the claims.
Of just over 40% of known doses, 284 were the first dose (100 accepted) and 453 the second (180 accepted).
“Third vaccinations and boosters currently represent a small number of claims and have therefore been included in the unspecified figures.”
District health boards
A list of where claimants lived by the District Health Board tops Waitemata with 208 followed by Waikato 195, Canterbury 162, Southern 161, Counties Manukau 146, Auckland 134 and Capital and Coast 113. The South Canterbury DHB recorded 14 complaints by residents.